India’s first mRNA-based COVID-19 vaccine

The Drugs Controller General of India (DGCI) gave nod for Phase-2 and Phase-3 trails of India’s first mRNA-based COVID-19 vaccine. First mRNA-based covid-19 vaccine, called HGCO19, is being developed by a Pune-based biotechnology company, Genova Biopharmaceuticals Ltd.

The company submitted its interim clinical data for Phase I study to the Central Drugs Standard Control Organization (CDSCO) to get the further approval. According to the Ministry of Science and Technology, interim Phase- I data suggests that HGCO19 vaccine is safe, tolerable, and immunogenic.

Published date : 26 Aug 2021 04:40PM